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Abstract
The time- and dose-dependent effects of wortmannin on transepithelial electrical resistance (Rte) and forskolin-stimulated
chloride secretion in T84 monolayer cultures were studied. In both instances, maximal effects developed over 2 h and were
stable thereafter. Inhibition of forskolin-stimulated chloride secretion, as measured by the short-circuit current (Isc)
technique, had an IC50 of 200^500 nM, which is 100-fold higher than for inhibition of phosphatidylinositol 3-kinase (PI3K),
but similar to the IC50 for inhibition of myosin light chain kinase (MLCK) and mitogen-activated protein kinases (MAPK).
Previous work demonstrated that 500 nM wortmannin did not inhibit the cAMP activation of apical membrane chloride
channels. We show here that 500 nM wortmannin has no affect on basolateral Na/K/2Cl-cotransporter activity, but inhibits
basolateral membrane Na/K-ATPase activity significantly. The MLCK inhibitors ML-7 and KT5926 were without affect on
forskolin-stimulated Isc. Similarly, the p38- and MEK-specific MAPK inhibitors SB203580 and PD98059 did not reduce
forskolin-stimulated Isc. In contrast, the non-specific MAPK inhibitor apigenin reduced forskolin-stimulated Isc and
basolateral membrane Na/K-ATPase activity similar to wortmannin. In isolated membranes from T84 cells, wortmannin did
not inhibit Na/K-ATPase enzymatic activity directly. We conclude that one or more MAPK may regulate the functional
expression of basolateral membrane Na/K-ATPase by controlling the abundance of enzyme molecules in the plasma
membrane. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The human colonic cell line T84 is a widely used
model for studies of epithelial chloride secretion [1].
These cells maintain a high degree of phenotypic
di¡erentiation and resemble colonic crypt cells in
function and morphology. T84 cells grow as structur-
ally polarized monolayers when cultured on perme-
able substrata and exhibit a large capacity for stimu-
lated chloride secretion in response to vasoactive in-
testinal peptide (VIP), L-adrenergic and cholinergic
agonists, histamine, and prostaglandin E1 [2]. The
activities and subcellular distribution of ion trans-
porters required for vectorial movement of chloride
ion across T84 monolayers conforms to the model of
epithelial chloride secretion ¢rst proposed more than
two decades ago [3]. As with most chloride secreting
epithelia, the chloride conductive properties of the
apical membrane are rate-limiting. In T84 cells, ap-
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ical chloride conductance is dominated by the cystic
¢brosis transmembrane conductance regulator
(CFTR), a cAMP-activated chloride channel highly
expressed in these cells [4,5]. Expressed at the baso-
lateral membrane is a bumetanide-inhibitable Na/K/
2Cl-cotransporter, which provides a pathway into
the cell for chloride ions [6]. The energy stored in
the outwardly directed sodium gradient, established
by the basolateral Na/K-ATPase, drives the accumu-
lation of intracellular chloride. Also, expressed at the
basolateral membrane are potassium channels that
facilitates potassium recycling across this membrane
[7], thus shunting the osmotic and electrical e¡ects of
excessive potassium accumulation. The importance
of each of these transporters to chloride secretion is
supported by the observations that inhibitors of any
one of them signi¢cantly reduces the magnitude of
secretagogue-stimulated chloride secretion [8].
The chloride secretory activity of T84 cells can be
in£uenced by an array of physiological and pharma-
cological agents [1,2,8]. Hormones and neurotrans-
mitters that stimulate chloride secretion can be
grouped into two broad categories; those that raise
intracellular cAMP (or cGMP) and those that raise
cytosolic calcium concentrations. In addition to se-
cretory agonists, a number of secretory antagonists
have been identi¢ed. These include somatostatin, ep-
idermal growth factor (EGF), and insulin [9].
The fungal metabolite wortmannin has become a
popular tool for unraveling the many roles for phos-
phatidylinositol 3-kinase (PI3K) and polyphosphati-
dylinositol lipids in practically all aspects of cellular
physiology [10]. Wortmannin is a potent (Ki = 5 nM),
selective, and fast acting inhibitor of most isoforms
of PI3K [11]. The PI3K-linked e¡ects wortmannin
has include inhibition of growth factor receptor-
mediated signal transduction, alterations in cytoskel-
etal structure, and disruption of multiple steps in
membrane vesicular tra⁄cking [10]. Wortmannin
has been used to demonstrate that the inhibitory ef-
fect of EGF on T84 chloride secretion is mediated by
phosphatidylinositol 3-kinase (PI3K) [12]. EGF stim-
ulates PI3K activity in T84 cells and 50 nM wort-
mannin blocks e¡ects of EGF on chloride secretion
stimulated by calcium-elevating secretagogues (e.g.
thapsigargin, carbachol, and histamine). EGF e¡ects
are due in part to inhibition of calcium-activated
potassium channels [9]. In contrast to inhibition of
calcium-stimulated chloride secretion, we reported
that PI3K-inhibiting concentrations of wortmannin
(i.e. 9 50 nM) have no signi¢cant a¡ect on cAMP-
stimulated chloride secretion by T84 cells [13]. Sim-
ilarly, others have reported that wortmannin does
not inhibit cAMP-stimulated chloride secretion in
HT29 cells, a second human colonic line [14]. How-
ever, when we tested higher wortmannin concentra-
tions, we observed signi¢cant inhibition of cAMP-
stimulated chloride secretion, which was not due to
reduced activity of apical membrane CFTR chloride
channels [13]. We concluded from this study that in-
hibition of cAMP-stimulated chloride secretion by
wortmannin above 100 nM is due to a¡ects on ion
transporters other than apical chloride channels and
to inhibition of regulatory enzymes in addition to
PI3K.
The aim of the present study was to characterize
more fully the e¡ects of wortmannin on the trans-
epithelial electrical properties and cAMP-stimulated
chloride secretory mechanisms in T84 cells. We have
attempted to use the wortmannin dose^response re-
lationship for cAMP-stimulated chloride secretion to
make predictions as to other regulatory enzymes that
are targets for wortmannin and that might regulate
chloride secretion in these cells. In addition, we have
assayed for e¡ects of wortmannin on the other ion
transport pathways that contribute to cAMP-stimu-
lated chloride secretion.
2. Materials and methods
2.1. Materials
Cell culture medium, antibiotics, and newborn calf
serum (NBCS) were from Sigma (St. Louis, MO).
The permeable supports used to culture T84 cells
as monolayers for electrophysiology were Millicell-
HA culture plate inserts (12 mm diameter; 0.6 cm2
surface area) from Millipore (Bedford, MA). Nysta-
tin, forskolin, and 8-(4-chlorophenylthio)-adenosine
3P :5P-cyclic monophosphate (cpt-cAMP) were from
Sigma. Wortmannin, apigenin, ouabain, KT5926,
PD98059, SB203580, and ML-7 were from Calbio-
chem (La Jolla, CA). All other chemicals and re-
agents were from Sigma or of the highest quality
available.
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2.2. Cell culture and transepithelial electrophysiology
Procedures for the maintenance of T84 cell stock
cultures, their growth as monolayers in Millicells,
and the assessment of monolayer development and
integrity by transepithelial electrical resistance (Rte)
measurements have been described elsewhere [3,15].
Measurements and computer-based data acquisition
of values for basal and forskolin-stimulated short-
circuit currents (Isc) and monolayer conductance
(G) were performed as previously described [13].
After T84 monolayers were mounted in Ussing
chambers and a stable basal Isc established (usually
1^3 WA/cm2), 10 WM forskolin was added to the ba-
solateral hemichamber. This caused the Isc to rise
sharply and to plateau at a new stable Isc within
10^15 min [13]. The value reported as forskolin-
stimulated Isc is the di¡erence between this plateau
value and the basal Isc.
Basolateral membrane Na/K-ATPase activity was
measured in T84 monolayers permeabilized with ap-
ical nystatin by methods similar to those described
previously [13,15].
2.3. Atomic absorption spectroscopy
To determine the cellular content of sodium and
potassium, T84 cells were grown in either 6- or 24-
well plates, respectively. The measurement of bume-
tanide-inhibitable potassium loss from cells cultured
in potassium-free solutions is an estimate of Na/K/
2Cl-cotransporter activity [16]. In experiments to de-
termine cotransporter activity, cultures were incu-
bated in bicarbonate-bu¡ered T84 Ringer with wort-
mannin or other test compounds as indicated for 2 h
and then switched to a potassium-free Ringer (com-
position in mM: 130 NaCl, 25 NaHCO3, 1.5 CaCl2,
1.5 MgCl2, 5 glucose, 0.005% phenol red) for 1 h.
Initial experiments showed that for cultures at ap-
proximately 70% con£uence, potassium loss was lin-
ear for up to 2 h. Following the 1-h incubation in
potassium-free Ringer ( þ test compounds), Ringer
was aspirated, culture wells rinsed 6U with ice-cold
0.1 M MgCl2, and culture plates air dried. For so-
dium determinations, con£uent cultures were washed
twice in T84 Ringer and cultured in T84 Ringer þ test
compounds for the times indicated. Ringer was aspi-
rated and cultures were washed in 0.1 M MgCl2 and
air-dried as described above. Dried cells were ex-
tracted with 2^4 ml of 1% HCl for 1 h at 20‡C.
Acidi¢ed cell extracts were analyzed for sodium
and potassium content on a Varian Spectra 5500
atomic absorption spectrophotometer using lamp set-
tings appropriate for each ion.
2.4. Sodium-potassium ATPase activity
Na/K-ATPase enzymatic activity was assayed in
plasma membrane pellets prepared from T84 cells
grown to con£uence in 100- or 150-mm dishes. In
some experiments, T84 cells were treated with wort-
mannin or apigenin prior to membrane isolation. For
this, cultures were incubated in bicarbonate-bu¡ered
T84 Ringer that contained wortmannin, apigenin or
DMSO (vehicle control) for 2.5 h. Culture medium
or Ringer was discarded and cultures were washed
twice with ice-cold phosphate-bu¡ered saline (PBS).
All subsequent steps were performed on ice unless
noted otherwise. Cultures were scraped into homog-
enization bu¡er (composition in mM: 50 mannitol,
5 HEPES (pH 7.4), 0.25 MgCl2, 1 ethylenediaminete-
traacetic acid (EDTA), 1 phenylmethylsulfonyl £uo-
ride (PMSF), 1 Wg/ml aprotinin, 2 Wg/ml leupeptin,
1 Wg/ml pepstatin, and 1Wg/ml N-tosyl-l-phenylala-
nine-chloromethyl ketone (TPCK)), brie£y disrupted
with a hand-held Dounce homogenizer, and soni-
cated with a Micro Ultrasonic Cell Disrupter
(Kontes, Vineland, NJ). Cell homogenates were cen-
trifuged at 1500Ug for 9 min to remove intact cells
and nuclei and again at 100 000Ug for 30 min to
obtain a post-nuclear membrane pellet. This ¢nal
pellet was resuspended in assay bu¡er (composition
in mM: 70 Tris^HCl (pH 7.0), 4.2 MgCl2, 84 NaCl,
14 KCl, and 0.14% Triton X-100) at 3.5^5 mg/ml
protein. The BCA Protein Assay (Pierce, Rockford,
IL) was utilized to determine protein content with
bovine serum albumin as standard. For the enzyme
activity assay, 100 Wl of isolated membranes was
combined with 250 Wl assay bu¡er, 5 Wl of 500 mM
NaN3, 5 Wl of 300 mM ouabain or DMSO, 10.5 Wl of
100 mM adenosine 5P-triphosphate (ATP). In some
experiments, wortmannin and apigenin were added
at this point from 1000X DMSO stocks. Assay tubes
were vortexed brie£y, incubated on ice for 20 min,
and then at 37‡C for 1 h. Enzymatic activity was
stopped by chilling tubes to 4‡C and addition of
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35 Wl of ice-cold 6 N perchloric acid (PCA). Tubes
were incubated on ice for 20 min and then centri-
fuged at 15 000Ug for 10 min. Duplicate 100 Wl
supernatant samples were combined with 1.4 ml of
acetate bu¡er (80 mM acetic acid, 18 mM sodium
acetate), 150 Wl of 1% ammonium molybdate, and
150 Wl of 1% ascorbic acid. Tubes were incubated
at room temperature for 10 min, and their absor-
bance read at 700 nm (Spectronic 601, Milton Roy,
Rochester, NY). Phosphate standards ranging from
5^25 Wg/ml were prepared using a 10-mM Na2HPO4
stock.
2.5. Measurement of cellular ATP content
T84 cells were grown to con£uence in 6-well plates.
Cultures were washed with bicarbonate-bu¡ered T84
Ringer at 37‡C. Cultures were incubated in Ringer
that contained wortmannin or other test compounds
for 2 h at 37‡C. Following this, the Ringer was aspi-
rated and 750 Wl of ice-cold 6% trichloroacetic acid
(TCA) was added to each well. Plates were agitated
on an orbital shaking platform for 15 min at 4‡C.
TCA extracts were transferred to microcentrifuge
tubes and spun at 10 000Ug for 2 min. A commercial
ATP assay kit (Sigma Cat. no. 366) was used to
measure the ATP content of a 500-Wl sample of the
cleared TCA extract. The assay is based on the ATP-
dependent enzymatic oxidation of nicotinamide ad-
enine dinucleotide.
2.6. Statistical analysis
Unless noted otherwise, all values are reported as
means þ standard error of the mean (S.E.M.). Statis-
tical signi¢cance (P9 0.05) was determined using
Student’s t test.
3. Results
3.1. Wortmannin reduces basal Rte and inhibits
forskolin-stimulated Isc
We have shown previously that up to 100 nM
wortmannin did not alter forskolin-stimulated Isc in
T84 monolayers under conditions that completely
inhibited phosphatidylinositol 3-kinase dependent
epidermal growth factor (EGF) responses [13]. To
obtain a more complete understanding of wortman-
nin e¡ects on the transepithelial electrical properties
of T84 monolayers, we began this study by monitor-
ing the e¡ects of wortmannin on transepithelial elec-
trical resistance (Rte) using the EVOM apparatus.
Monolayer Rte was measured at 1-h intervals follow-
ing the addition of 50 or 500 nM wortmannin (Fig.
1). At 50 nM, wortmannin caused a 15^20% reduc-
tion in Rte that was stable after 1 h. At 500 nM, the
reduction in Rte reached 50% by 2 h and was stable
out to 12 h (not shown).
Brief exposure of T84 monolayers to wortmannin
(500 nM for 15 min) did not a¡ect the magnitude of
a subsequent forskolin-stimulated Isc responses, but
longer exposures (v 30 min) signi¢cantly reduced for-
skolin-stimulated Isc [13]. To access time-dependent
e¡ects of wortmannin on stimulated chloride secre-
tion, T84 monolayers were cultured with 200 nM
wortmannin for varying lengths of time prior to
mounting in Ussing chambers and measurement of
forskolin-stimulated Isc. At 200 nM wortmannin,
maximum inhibition of forskolin-stimulated Isc was
Fig. 1. Wortmannin reduces the transepithelial electrical resis-
tance (Rte) of T84 monolayer cultures. Culture media bathing
the apical and basolateral surfaces of con£uent monolayers was
removed and replaced with serum-free culture medium that con-
tained the indicated concentrations of wortmannin or 0.1%
DMSO (vehicle control). Values for Rte were measured with the
EVOM apparatus immediately after £uid exchange (t = 0) and
at hourly intervals. Shown is a representative experiment from
three replicates. Values are the mean þ S.E.M. for three mono-
layers in each group. The mean Rte value at t = 0 for all mono-
layers shown was 980 þ 95 6cm2.
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50% and was observed at 2 h (Fig. 2A). In a subse-
quent series of experiments, monolayers were incu-
bated with 200 nM wortmannin for 2 h and their
response to 500 WM cpt-cAMP measured. In these
experiments, wortmannin reduced cpt-cAMP-stimu-
lated Isc by 37% (46.7 þ 1.8 vs. 29.5 þ 1.8 WA/cm2 ;
n = 5, P6 0.01) demonstrating that inhibition by
wortmannin is not due to e¡ects on forskolin activa-
tion of adenyl cyclase.
Using a 2-h preincubation, a wortmannin dose^
response curve for inhibition of forskolin-stimulated
Isc was obtained (Fig. 2B). Under these conditions,
the maximum inhibition was 75% at 2 WM and the
IC50 was in the range of 200^500 nM. This is approx-
imately two orders of magnitude greater than the
reported IC50 for inhibition of PI-3K [11] and phos-
pholipase A2 [17], but is within the reported range
for inhibition of myosin light chain kinase (MLCK)
[18] and mitogen-activated protein (MAP) kinase
[19].
3.2. Wortmannin does not inhibit
Na/K/2Cl-cotransporter activity
The basolateral membrane Na/K/2Cl-cotransport-
er is required for sustained chloride secretion and a
potential target for wortmannin inhibition. To deter-
mine the e¡ect of wortmannin on the Na/K/2Cl-co-
transporter we exploited its ability to catalyze trans-
port across the plasma membrane in either direction
depending on the sum of the concentration gradients
for its substrate ions. When extracellular potassium
is removed, the net driving force for transport is in
the outward direction. Measurement of the bumeta-
nide-inhibitable potassium loss from cells in potassi-
um-free solutions is an estimate of cotransporter ac-
tivity [16]. Fig. 3 shows that switching T84 cells to
potassium-free Ringer resulted in a 33 þ 3% loss of
cell potassium. Bumetanide reduced this potassium
loss to 23 þ 4%. Thus, about one-third of the potas-
sium loss in these cells was through the cotransporter
(i.e. bumetanide inhibited). Inclusion of 500 nM
wortmannin had no a¡ect on potassium loss, but
increased the bumetanide-sensitive component of po-
tassium loss by a factor of two (36 þ 4.6% vs.
16.1 þ 4.5% potassium loss in the absence and pres-
ence of bumetanide, respectively). This suggests that
wortmannin actually stimulates cotransporter activ-
Fig. 2. Wortmannin inhibits forskolin-stimulated Isc. (A) The
time-dependent inhibition of forskolin-stimulated Isc by 200 nM
wortmannin. Monolayers were treated with either 200 nM wort-
mannin or 0.1% DMSO for the indicated times, mounted in
Ussing chambers, and the Isc response to 1035 M forskolin
measured. Each point is the mean ( þ S.E.M.) for forskolin-
stimulated Isc from four monolayers. (B) Dose-dependent inhi-
bition of forskolin-stimulated Isc by wortmannin. T84 mono-
layers were treated with increasing concentrations of wortman-
nin for 2 h and the Isc response to 1035 M forskolin measured.
Each point is expressed as a percent of the vehicle control
(0.1% DMSO) values and represents the mean ( þ S.E.M.) of 8
or more monolayers. Forskolin-stimulated Isc in the 0.1%
DMSO controls was 35.8 þ 1.5 WA/cm2 (n = 8).
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ity. When 1035 M forskolin was included in the po-
tassium-free Ringer, potassium loss was increased to
53 þ 2% and bumetanide reduced this to 43 þ 1%.
The absolute size of the bumetanide-sensitive potas-
sium loss was similar with and without forskolin,
suggesting that the forskolin-stimulated potassium
loss is not due to activation of the cotransporter
under these conditions. Inclusion of 500 nM wort-
mannin with forskolin had no signi¢cant e¡ect on
bumetanide-sensitive potassium loss (50 þ 3% vs.
40 þ 3% in the absence and presence of bumetanide,
respectively). These results strongly suggest that
wortmannin has no inhibitory e¡ect on cotransporter
activity.
3.3. Wortmannin inhibits the Na/K-ATPase
We have used nystatin to permeabilize apical
membranes of monolayer cultures and measured
the resulting ouabain-inhibitable sodium current
(INa) to address whether the basolateral membrane
Na/K-ATPase is a target for wortmannin. Permeabi-
lization was carried out in symmetric Ringer solu-
tions to eliminate current £ow through tight junc-
tions or active ion channels present in basolateral
membranes. As shown in Fig. 4, addition of 0.35
mg/ml nystatin caused a rapid increase in INa, which
was accompanied by a gradual increase in monolayer
conductance (Gnyst) (not shown). The increase in INa
was completely reduced by 1034 M ouabain (Fig. 4).
The magnitude of INa following nystatin was signi¢-
cantly lower in wortmannin-treated cultures (Fig. 4
and Table 1). In addition, Gnyst was reduced in wort-
mannin-treated monolayers (Table 1) indicating that
wortmannin inhibited the basal ion conductive prop-
Fig. 4. Wortmannin inhibits Na/K-ATPase activity in T84
monolayers. Millicell cultures were treated with wortmannin or
0.1% DMSO (vehicle control) as indicated for 2 h prior to
mounting in Ussing chambers. Addition of 0.35 Wg/ml nystatin
to the apical hemichamber caused an immediate increase in cur-
rent (INa) that was almost completely (v 95%) inhibited by
1034 M ouabain. (A) Individual monolayer recordings from a
typical experiment. (B) Means ( þ S.E.M.) for 8^16 monolayers
in each group.
Fig. 3. Wortmannin does not inhibit Na/K/2Cl-cotransporter
activity. T84 cells grown to 70% con£uence in 24-well plates
were treated with 500 nM wortmannin or 0.1% DMSO in
HCO3-bu¡ered T84 Ringer for 2 h. Cultures were then
switched to a potassium-free T84 Ringer that contained 500
nM wortmannin, 1035 M forskolin and 1034 M bumetanide as
indicated and incubated for an additional 60 min at 37‡C. At
this point, cell potassium was measured as described in Section
2. Fractional potassium loss is the di¡erence in potassium con-
tent between cultures in normal Ringer and potassium-free
Ringer. Each bar represents the mean ( þ S.E.M.) of 6^10 sepa-
rate culture wells from two di¡erent experiments. The di¡erence
between solid and open bars is the bumetanide-inhibitable com-
ponent of potassium e¥ux and a measure of Na/K/2Cl-cotran-
sport activity.
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erties of T84 basolateral membranes. Addition of
forskolin (1035 M) after nystatin permeabilization
had no e¡ect on INa (not shown) suggesting that
wortmannin inhibition of forskolin-stimulated Isc in
intact cells is due to inhibition of basal Na/K-ATP-
ase activity. Consistent with inhibition of Na/K-
ATPase activity, 500 nM wortmannin caused a
30% increase in T84 cell sodium content as measured
by atomic absorption spectrophotometry (Fig. 5).
3.4. Wortmannin may target a MAPK activity in
T84 cells
Wortmannin inhibition of forskolin-stimulated Isc
has an IC50 of 200^500 nM, which is similar to the
reported e¡ects of wortmannin on MLCK
(IC50 = 200 nM) [18] and MAP kinase (IC50 = 300
nM) [19]. To test whether either of these enzymes
are targets for wortmannin, we have studied the ef-
fects of MLCK and MAP kinase inhibitors on for-
skolin-stimulated Isc. As shown in Table 2, preincu-
bation of T84 monolayers for 2 h with the MLCK
inhibitors ML-7 and KT5926 did not alter forskolin-
stimulated Isc. In companion cultures, 1 WM ML-7
inhibited horseradish peroxidase endocytosis by T84
cells (Dickson and Ecay, unpublished) suggesting
that the lack of ML-7 e¡ects on forskolin-stimulated
Isc was not due to reduced potency of our ML-7
stocks.
We cultured T84 monolayers with several MAP
kinase inhibitors to test the possibility that wortman-
nin might be acting through this pathway to inhibit
forskolin-stimulated Isc. The MAP kinase kinase or
MEK-speci¢c inhibitor PD98059 (20 WM) caused a
Table 2
E¡ects of MLCK and MAP kinase inhibitors on forskolin-stimulated Isc in T84 monolayer cultures
Inhibitor Target Ki or IC50 (WM) Forskolin-stimulated Isc (WA/cm2)
0.1% DMSO 20.2 þ 0.9 (n = 10)
1 WM ML-7 MLCK 0.3 22.1 þ 1.7 (n = 9)
0.1 WM KT5926 MLCK 0.018 21.4 þ 1.2 (n = 5)
0.1% DMSO 36.0 þ 3.9 (n = 9)
100 WM Apigenin MAP Kinase 10 10.8 þ 3.9 (n = 9)a
20 WM PD98059 MAP kinase kinase (MEK) 2 36.6 þ 0.3 (n = 4)
10 WM SB203580 p38 0.6 42.9 þ 1.2 (n = 4)b
aP6 0.01 vs. 0.1% DMSO control.
bP6 0.05 vs. 0.1% DMSO control.
Fig. 5. Wortmannin and apigenin increase the sodium content
of T84 cells. Con£uent cultures of T84 cells were washed twice
in T84 Ringer and treated with the indicated drugs for 2 h.
Cultures were washed free of extracellular sodium, extracted in
0.1% HCl and the sodium content of cell extracts measured by
atomic absorption spectrophotometry as described in Section 2.
Cell extract sodium content was normalized to values measured
in 0.1% DMSO control cultures. Each value represent the mean
( þ S.E.M.) for nine separate cultures.
Table 1
E¡ects of wortmannin and apigenin on INa and Gnyst in nysta-
tin-permeabilized T84 monolayers
Treatment na vINa (WA/cm2) vGnyst (mS/cm2)
0.1% DMSO control 17 88.3 þ 3.9 10.4 þ 0.8
500 nM Wortmannin 19 69.2 þ 2.8b 8.0 þ 0.6c
100 WM Apigenin 8 55.0 þ 3.7b 4.5 þ 0.6b
aNumber of monolayers tested in each group.
bP6 0.01 vs. DMSO control.
cP6 0.05 vs. DMSO control.
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small, but insigni¢cant, reduction in forskolin-stimu-
lated Isc (Table 2). In contrast, the p38 speci¢c in-
hibitor SB203580 (10 WM) caused a small and signi¢-
cant increase in forskolin-stimulated Isc (Table 2).
Apigenin is an antiproliferative £avone that inhibits
the MAP kinase signaling pathway, though the pre-
cise target of apigenin inhibition has not been iden-
ti¢ed [20]. In T84 cells, apigenin inhibited forskolin-
stimulated Isc strongly (Table 2), but had less of an
e¡ect on Rte than wortmannin. After 2 h, 100 WM
apigenin reduced Rte by only 10 þ 2% (n = 14). Like
wortmannin, 100 WM apigenin reduced the INa ob-
served upon nystatin permeabilization (Table 1), and
increased the sodium content of T84 cells by 80%
(Fig. 5). The similar e¡ects of apigenin and wort-
mannin on INa and cell sodium content suggest
that one or more steps in the MAP kinase signalling
cascade may be regulating Na/K-ATPase activity in
T84 cells.
3.5. Wortmannin does not inhibit Na/K-ATPase
activity directly
The reduced ouabain-inhibitable INa in wortman-
nin-treated T84 monolayers could result from: (1)
direct inhibition of Na/K-ATPase activity by wort-
mannin; (2) wortmannin-stimulated degradation of
the Na/K-ATPase protein; (3) a redistribution of
Na/K-ATPase protein from the plasma membrane
to intracellular membranes in response to wortman-
nin; or (4) reduced ATP levels in wortmannin-
treated cells. To address these possibilities, we have
measured wortmannin e¡ects on Na/K-ATPase enzy-
matic activity and the ATP level in wortmannin-
treated cells.
In isolated membrane preparations, 2 WM wort-
mannin did not reduce Na/K-ATPase activity (Fig.
6A) demonstrating that it does not inhibit the en-
zyme directly. In contrast, 100 WM apigenin inhibited
Na/K-ATPase activity in isolated membranes by ap-
proximately 35%. To address the possibility that
wortmannin promotes the degradation of the Na/
K-ATPase protein, we treated T84 cells with wort-
mannin for 2.5 h prior to membrane isolation and
enzyme assay. As shown in Fig. 6B, Na/K-ATPase
activity was not reduced in membranes isolated from
wortmannin-treated cells. The experiments illustrated
in Fig. 6 suggest that wortmannin does not reduce
Na/K-ATPase activity directly or reduce the total
level of Na/K-ATPase activity in cells. In contrast,
apigenin signi¢cantly reduced Na/K-ATPase activity
in membranes isolated from treated cells (Fig. 6B).
Thus, apigenin di¡ers from wortmannin in that it
causes direct inhibition of Na/K-ATPase activity
and a reduction in total Na/K-ATPase activity in
Fig. 6. Wortmannin does not inhibit the Na/K-ATPase enzy-
matic activity of T84 membranes. In A, T84 cells were homoge-
nized and a crude membrane fraction prepared. Samples of the
membrane fraction were treated with the indicated compounds
and assayed for Na/K-ATPase activity. Values are expressed as
a percent of activity in the control membranes (40^160 Wg PO4/
h/mg protein) and are the mean ( þ S.E.M.) of four separate
membrane preparations with triplicate determinations made for
each group (*P9 0.05 vs. 0.1% DMSO control). In B, cultures
were treated with DMSO, wortmannin, or apigenin for 2 h pri-
or to homogenization and membrane isolation. Values are ex-
pressed as a percent of activity in the control membranes (40^
190 Wg PO4/h/mg protein) and are the mean ( þ S.E.M.) of three
separate membrane preparation with triplicate determinations
made for each group.
BBAMEM 77866 24-7-00
T.W. Ecay et al. / Biochimica et Biophysica Acta 1467 (2000) 54^64 61
treated cells. This latter e¡ect could result from api-
genin-stimulated degradation of Na/K-ATPase sub-
unit proteins or from an inhibitory mechanism that is
retained in our broken cell preparations.
To determine whether wortmannin or apigenin re-
duced cellular ATP levels, which could lead to dimin-
ished sodium pumping activity, we measured ATP
levels in T84 cultures treated with wortmannin or
apigenin for 2 h. Wortmannin treatment resulted in
no change in ATP levels relative to the 0.1% DMSO
control cultures, while apigenin caused a 10% reduc-
tion in ATP that was statistically signi¢cant (Table
3). The mitochondrial uncoupler dinitrophenol re-
duced ATP levels by 62 þ 3% in T84 cultures.
4. Discussion
Wortmannin has been shown to reduce Rte in
MDCK monolayers and to inhibit the development
of Rte in a rat mammary tumor cell line [21,22].
These e¡ects are presumed to be linked to inhibition
of PI3K activity by the low concentration of wort-
mannin required, and in the case of the mammary
tumor cell study, the similar e¡ects produced by a
second PI3K inhibitor, LY294002. We have found
that 50 nM wortmannin partially reduced Rte in
T84 monolayers, which is consistent with a role for
PI3K in the maintenance of T84 tight junction integ-
rity. However, 500 nM wortmannin produced a sig-
ni¢cantly greater reduction in Rte, suggesting that
other wortmannin-sensitive enzymes are involved in
maintaining T84 cell tight junction integrity.
We have shown previously that 50 nM wortman-
nin produced no signi¢cant inhibition of forskolin-
stimulated chloride secretion and we concluded that
PI3K is not involved in this process [13]. We have
now demonstrated that greater than 50 nM wort-
mannin produces signi¢cant inhibition of forskolin-
stimulated chloride secretion, but that the full inhib-
itory e¡ect of wortmannin requires 2 h to develop.
At 2 h, the observed IC50 for inhibition of forskolin-
stimulated chloride secretion was 200^500 nM. Low
permeability of T84 membranes to wortmannin is
unlikely to account for the time-dependent e¡ect
since complete blockade of EGF inhibition of thap-
sigargin-stimulated chloride secretion by 50 nM
wortmannin occurs within 30 min [12,13]. In addi-
tion, we have shown that apical membrane chloride
channel activity, is not a¡ected by 500 nM wortman-
nin [13]. Here we show that basolateral Na/K/2Cl-
cotransporter activity, as measured in a bumetanide-
inhibitable potassium e¥ux assay, was not reduced
by 500 nM wortmannin. In contrast, wortmannin
reduced basolateral membrane sodium pump activity
signi¢cantly. Consistent with sodium pump inhibi-
tion, wortmannin elevated T84 cell sodium content.
Reduced Na/K-ATPase activity and elevated cell so-
dium can diminish stimulated chloride secretion in at
least two ways. First, elevated sodium will reduce the
driving force for chloride in£ux via the Na/K/2Cl-
cotransporter resulting in lowered cytosolic chloride
and reduced current £ow through cAMP-activated
chloride channels. Second, pump inhibition will de-
polarize the plasma membrane, again reducing the
driving force for chloride exit through open chloride
channels. Both of these possibilities would be ex-
pected to reduce cAMP-stimulated chloride secre-
tion.
We have not assayed the e¡ects of wortmannin on
basolateral potassium channels directly. However,
data from nystatin permeabilization studies suggests
that wortmannin inhibits these as well. Wortmannin
decreased Rte in intact monolayers, suggesting an
increase in tight junction permeability. We would
have predicted an increase in the conductance of
nystatin-permeabilized monolayers if wortmannin af-
fected tight junctions only. However, wortmannin
reduced the conductance of nystatin-permeabilized
monolayers. This observation suggests that wort-
mannin reduces basolateral membrane channel activ-
ity at the same time that it increases tight junction
permeability. Whether these are potassium channels
has not been determined, but the e¡ect of reduced
basolateral potassium channel activity would be to
inhibit chloride secretion [1,7].
Table 3
E¡ects of wortmannin and apigenin on T84 cell ATP content
Treatment ATP (nmol/mg protein)
0.1% DMSO 83.1 þ 2.7 (n = 9)
2 WM Wortmannin 86.3 þ 4.0 (n = 9)
100 WM Apigenin 75.7 þ 1.9 (n = 9)a
500 WM Dinitrophenol 32.2 þ 2.5 (n = 3)b
aP9 0.05 vs. 0.1% DMSO control.
bP9 0.01 vs. 0.1% DMSO control.
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Another question to be addressed concerns the
mechanism by which wortmannin reduces basolateral
membrane Na/K-ATPase in T84 cells. Ours is at
least the second report of wortmannin-sensitive Na/
K-ATPase activity in epithelia. In rat proximal tu-
bules, dopamine reduces basolateral membrane Na/
K-ATPase activity by stimulating endocytosis of the
Na/K-ATPase protein [23]. Wortmannin blocks dop-
amine-stimulated PI3K activity and Na/K-ATPase
endocytosis in these cells [24]. Our results di¡er
from those in proximal tubule cells because the 500
nM wortmannin required to inhibit Na/K-ATPase
activity in T84 cells is ten times that required to fully
inhibit PI3K activity [12,13] Thus, the molecular tar-
get for wortmannin must di¡er between the two sys-
tems. However, our observations support a similar
hypothesis in which wortmannin in£uences Na/K-
ATPase activity in basolateral membranes by altering
rates of Na/K-ATPase endocytosis and exocytosis.
The development of wortmannin inhibition over
time in T84 cells suggests that wortmannin does
not interrupt a signal transduction pathway, but af-
fects a continuous process that runs down over time.
We suggest that this process is either the delivery of
new pumps to the cell surface or the endocytic recy-
cling of pumps as part of normal membrane turnover
processes. Consistent with this hypothesis, wortman-
nin does not inhibit Na/K-ATPase activity directly
and does not reduce the total cellular content of
the enzyme in treated cells. This suggests that wort-
mannin-treated cells possess the same amount of Na/
K-ATPase activity, but that less of it is in basolateral
membranes.
Wortmannin inhibition of forskolin-stimulated
chloride secretion has an IC50 of 200^500 nM, which
is similar to reported e¡ects of wortmannin on
MLCK and MAP kinase [18,19]. In T84 cells, we
have ruled out MLCK inhibition by showing that
the MLCK inhibitors ML-7 and KT5926 do not re-
duce forskolin-stimulated Isc. Similarly, MEK and
p38 speci¢c MAP kinase inhibitors do not inhibit
chloride secretion. On the contrary, the p38 inhibitor
SB203580 produced a small, but signi¢cant, stimula-
tion of forskolin-stimulated chloride secretion. How-
ever, the very general MAP kinase inhibitor apigenin
[20] reduced forskolin-stimulated chloride secretion
and Na/K-ATPase activity, and increased cell so-
dium content similar to wortmannin. This suggests
that one or more MAP kinases regulate Na/K-ATP-
ase activity, an observation that has not been re-
ported in T84 or any other epithelial cell line. In
addition, e¡ects of apigenin on PI3K or MLCK
have not been reported. In a human airway cell
line, apigenin and other £avonoids stimulate chloride
secretion at low concentrations (6 30 WM) and in-
hibit forskolin-stimulated chloride secretion at high
concentrations (s 30 WM) [25].
It is important to note that the e¡ects of wortman-
nin and apigenin are not the result of generalized
cytotoxicity in T84 cells. Wortmannin did not reduce
ATP levels in T84 cells. Although apigenin caused a
10% reduction in ATP levels, this is not su⁄cient to
account for its 70% reduction in forskolin-stimulated
Isc. In addition, apigenin was not as e¡ective as wort-
mannin at reducing Rte values. Finally, the caveats
associated with any inhibitor study must be applied
here. The e¡ect of wortmannin on Na/K-ATPase
activity is relatively selective as it did not inhibit
cAMP activation of apical membrane CFTR chlo-
ride channels [13] or activity of the basolateral mem-
brane Na/K/2Cl-cotransporter. However, at the con-
centrations used here, wortmannin may be inhibiting
other important regulatory proteins in addition to or
di¡erent from MAP kinases.
A link between Na/K-ATPase activity and the
MAP kinase signaling pathway has been reported
in cardiac myocytes and HeLa cells [26,27]. Ouabain
inhibition of ATPase activity causes activation of
MEK in both cell types. In cardiac myocytes, oua-
bain alters gene expression patterns similar to hyper-
trophic stimuli [26]. In MDCK cells, ouabain acti-
vates protein tyrosine phosphorylation and
promotes the redistribution of cell adhesion mole-
cules and detachment of cells from the substrata
[28]. While these studies demonstrate that Na/K-
ATPase can regulate MAP kinases and related path-
ways, our results suggest that these pathways can
regulate the functional expression of Na/K-ATPase
in epithelial cells. We hypothesize that cells maintain
a feedback loop in which activated MAP kinases
promote the insertion or retention of Na/K-ATPase
proteins in the plasma membrane. When Na/K-ATP-
ase levels in the plasma membrane rise su⁄ciently, its
activity can turn o¡ or turn down activated MAP
kinases. If Na/K-ATPase activity in the plasma mem-
brane falls, analogous to ouabain treatment, MAP
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kinases are stimulated to, among other things, boost
Na/K-ATPase levels in the plasma membrane.
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